Improving Communication Between Cancer Patients & Oncologists
NCT ID: NCT02969031
Last Updated: 2020-01-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2017-02-14
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Patient Experience in Cancer Care
NCT01621295
Communication Training for Cancer Patients, Their Caregivers, and Their Doctors
NCT04479605
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
NCT06955468
Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study
NCT05352451
Geriatric Communication Skills Training Program for Oncology Clinicians
NCT03530969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced SCOPE training
Complete a baseline questionnaire, administer satisfaction surveys anonymously to a sample of their patients, audio record (using a smartphone application) eight clinic visits with eight different patients. Receive survey feedback as well as the enhanced SCOPE program that provides feedback on their audio-recorded encounters via a web-based interactive program.
Enhanced SCOPE training
Intervention is integrated into the American Board of Internal Medicine (ABIM) Maintenance Of Certification (MOC) process.
Standard Communication training
Complete a baseline questionnaire, administer satisfaction surveys anonymously to a sample of their patients. Receive the results of the patient surveys and be asked to conduct a quality improvement activity of their own design that responds to the feedback (the current "standard" communication PIM).
Standard Communication training
Standard Communication training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced SCOPE training
Intervention is integrated into the American Board of Internal Medicine (ABIM) Maintenance Of Certification (MOC) process.
Standard Communication training
Standard Communication training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a study-compatible smart phone.
* Eligible patients will have metastatic cancer.
* At least 18 years of age.
* Speak and read English.
* Receive oncology care from an enrolled oncologist.
Exclusion Criteria
* Patients who do not speak English.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Board of Internal Medicine
OTHER
Duke University
OTHER
Patient-Centered Outcomes Research Institute
OTHER
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James A. Tulsky
Chair, Department of Psychosocial Oncology and Palliative Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James A. Tulsky, MD
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Patient-Centered Outcomes Research Institute (PCORI) Research Award Listing
Dana Farber Cancer Institute (DFCI), Department of Psychosocial Oncology and Palliative Care (POPC) Listing of Current Research and PCORI Award
Vital Talk is a non-profit whose mission is to nurture healthier connections between patients and clinicians. We are using Vital Talk intellectual property (e.g., REMAP) for the intervention
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.